calmidazolium has been researched along with 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Church, D; North, RA; Surprenant, A; Virginio, C | 1 |
| Chessell, IP; Humphrey, PP; Kaur, R; Michel, AD | 1 |
2 other study(ies) available for calmidazolium and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
| Article | Year |
|---|---|
Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Cations, Divalent; Cell Line; Enzyme Inhibitors; Humans; Imidazoles; In Vitro Techniques; Kidney; Magnesium; Patch-Clamp Techniques; Protons; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Spectrometry, Fluorescence | 1997 |
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Antibodies, Blocking; Benzoxazoles; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Inhibitors; Fluorescent Dyes; Humans; Imidazoles; In Vitro Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Stimulation, Chemical | 2000 |